Isosaponarin

CAS No. 19416-87-6

Isosaponarin ( —— )

Catalog No. M23203 CAS No. 19416-87-6

Isosaponarin is a flavone glycoside isolated from wasabi leaves.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 710 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Isosaponarin
  • Note
    Research use only, not for human use.
  • Brief Description
    Isosaponarin is a flavone glycoside isolated from wasabi leaves.
  • Description
    Isosaponarin is a flavone glycoside isolated from wasabi leaves. Isosaponarin increases collagen synthesis, caused by up-regulated TGF-β type II receptor (TβR-II) and prolyl 4-hydroxylase (P4H) proteins production.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    TGF-beta/Smad
  • Target
    TGFBR
  • Recptor
    Collagen synthesis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    19416-87-6
  • Formula Weight
    594.52
  • Molecular Formula
    C??H??O??
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Masashi Nagai, et al. The effect of isosaponarin isolated from wasabi leaf on collagen synthesis in human fibroblasts and its underlying mechanism. J Nat Med. 2010 Jul;64(3):305-12.
molnova catalog
related products
  • Protein Kinase C 19-...

    Protein Kinase C (19-31), a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase C substrate peptide for testing the protein kinase C activity.

  • IN-1233 phosphate

    A potent and selective TGF-βRI (ALK5) inhibitor with IC50 of 34 nM.

  • Pentabromophenol

    Pentabromophenol suppressed TGF-β response by accelerating the turnover rate of TGF-β receptors.